FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+12.72%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
(-18%)
Cap. Flow
-$140M
Cap. Flow
% of AUM
-36.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$1.49M |
Top Sells
| 1 |
10x Genomics
TXG
|
$142M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $355M | 93.6% |
2,503,528
-1,000,000
| -29% | -$142M |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $10.9M | 2.87% |
1,000,002
+137,600
| +16% | +$1.49M |
|
3
Novavax
NVAX
$1.21B
| $7.51M | 1.98% |
67,373
| – | – |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.87M | 1.55% |
45,884
| – | – |
|